$SBIG
springbig Holdings Inc

2022 Q4 Form 10-Q Financial Statement

#000180160222000034 Filed on November 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q4
Revenue $6.757M $7.456M $0.00
YoY Change -100.0%
Cost Of Revenue $1.480M $1.912M $1.619M
YoY Change -8.59% 22.56% 7.22%
Gross Profit $5.277M $5.544M $4.980M
YoY Change 5.96% 21.55% 55.63%
Gross Profit Margin 78.1% 74.36%
Selling, General & Admin $6.914M $6.290M $4.360M
YoY Change 58.58% 54.17% 54.06%
% of Gross Profit 131.02% 113.46% 87.55%
Research & Development $2.995M $2.811M $2.760M
YoY Change 8.51% 46.71% 84.0%
% of Gross Profit 56.76% 50.7% 55.42%
Depreciation & Amortization $68.00K $67.00K $173.0K
YoY Change -60.69% 34.0% 1630.0%
% of Gross Profit 1.29% 1.21% 3.47%
Operating Expenses $9.976M $9.101M $1.499M
YoY Change 565.67% 3190.91% -65.47%
Operating Profit -$4.699M -$3.557M $3.481M
YoY Change -234.98% 147.87% -405.38%
Interest Expense -$306.0K -$313.0K $3.280K
YoY Change -9429.27% -2308.89%
% of Operating Profit 0.09%
Other Income/Expense, Net $467.0K $811.0K $320.0K
YoY Change 45.94% -90.61%
Pretax Income -$4.538M $156.0K -$1.175M
YoY Change 286.09% -98.14% 4.01%
Income Tax $3.000K $0.00 $2.000K
% Of Pretax Income 0.0%
Net Earnings -$4.541M -$3.059M -$1.175M
YoY Change 286.35% -136.51% 4.01%
Net Earnings / Revenue -67.2% -41.03%
Basic Earnings Per Share -$0.12
Diluted Earnings Per Share -$0.17 -$0.12 -$21.54K
COMMON SHARES
Basic Shares Outstanding 26.21M shares 25.63M shares
Diluted Shares Outstanding 25.63M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.546M $6.806M $621.5K
YoY Change 470.58% 839.47%
Cash & Equivalents $3.500M $6.800M $621.5K
Short-Term Investments
Other Short-Term Assets $1.505M $2.425M $259.9K
YoY Change 478.98% 606.73%
Inventory
Prepaid Expenses $259.9K
Receivables $3.222M $4.727M $3.045M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $8.273M $14.31M $881.4K
YoY Change 838.61% 1240.04% 374.51%
LONG-TERM ASSETS
Property, Plant & Equipment $1.125M $434.0K $480.0K
YoY Change 134.38% -9.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0M
YoY Change
Total Long-Term Assets $1.384M $690.0K $200.0M
YoY Change -99.31% -99.66% 47860.67%
TOTAL ASSETS
Total Short-Term Assets $8.273M $14.31M $881.4K
Total Long-Term Assets $1.384M $690.0K $200.0M
Total Assets $9.657M $15.00M $200.9M
YoY Change -95.19% -92.54% 33228.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.056M $1.246M $412.0K
YoY Change 156.31% 412.88%
Accrued Expenses $3.019M $1.342M $108.0K
YoY Change 2695.37% 1142.59%
Deferred Revenue $291.0K $330.0K $450.0K
YoY Change -35.33% -19.64%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.451M $4.999M $0.00
YoY Change
Total Short-Term Liabilities $10.27M $9.093M $1.663M
YoY Change 517.65% 2491.04% 185.37%
LONG-TERM LIABILITIES
Long-Term Debt $3.050M $5.000M $0.00
YoY Change
Other Long-Term Liabilities $654.0K $805.0K $16.44M
YoY Change -96.02% -95.2%
Total Long-Term Liabilities $3.704M $5.805M $16.44M
YoY Change -77.47% -65.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.27M $9.093M $1.663M
Total Long-Term Liabilities $3.704M $5.805M $16.44M
Total Liabilities $13.98M $14.90M $18.10M
YoY Change -22.79% -12.93% 3005.75%
SHAREHOLDERS EQUITY
Retained Earnings -$26.30M -$21.80M -$17.19M
YoY Change 53.03% 339289.49%
Common Stock $3.000K $3.000K $2.000K
YoY Change 50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.321M $98.00K -$17.19M
YoY Change
Total Liabilities & Shareholders Equity $9.657M $15.00M $200.9M
YoY Change -95.19% -92.54% 33228.73%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q4
OPERATING ACTIVITIES
Net Income -$4.541M -$3.059M -$1.175M
YoY Change 286.35% -136.51% 4.01%
Depreciation, Depletion And Amortization $68.00K $67.00K $173.0K
YoY Change -60.69% 34.0% 1630.0%
Cash From Operating Activities -$2.200M -$7.366M -$103.0K
YoY Change 2036.34% 11137.22% -90.81%
INVESTING ACTIVITIES
Capital Expenditures $11.00K -$30.00K $252.0K
YoY Change -95.63% -50.0% 404.0%
Acquisitions
YoY Change
Other Investing Activities -$3.000K -$6.000K $0.00
YoY Change
Cash From Investing Activities -$14.00K -$36.00K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.047M 30.00K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.200M -7.366M -103.0K
Cash From Investing Activities -14.00K -36.00K 0.000
Cash From Financing Activities -1.047M 30.00K 0.000
Net Change In Cash -3.261M -7.372M -103.0K
YoY Change 3066.63% 11146.38% -91.05%
FREE CASH FLOW
Cash From Operating Activities -$2.200M -$7.366M -$103.0K
Capital Expenditures $11.00K -$30.00K $252.0K
Free Cash Flow -$2.211M -$7.336M -$355.0K
YoY Change 522.85% 132080.18% -69.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Central Index Key
EntityCentralIndexKey
0001801602
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40049
dei Entity Registrant Name
EntityRegistrantName
SPRINGBIG HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-2789488
dei Entity Address Address Line1
EntityAddressAddressLine1
621 NW 53rd Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 260
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton,
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33487
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
972-9172
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2227000 usd
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26211914 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6806000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4727000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3045000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
348000 usd
CY2021Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
364000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2425000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
927000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
14306000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
6563000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
434000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2584000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
480000 usd
CY2022Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent
256000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent
0 usd
CY2022Q3 us-gaap Assets
Assets
14996000 usd
CY2021Q4 us-gaap Assets
Assets
7043000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1246000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
412000 usd
CY2022Q3 wdq Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
2518000 usd
CY2021Q4 wdq Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
1722000 usd
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
4999000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
330000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
450000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9093000 usd
CY2022Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
5000000 usd
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2022Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
805000 usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0 usd
CY2022Q3 us-gaap Liabilities
Liabilities
14898000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2584000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26211914 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26211914 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
22764527 shares
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7456000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6121000 usd
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17862108 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17862108 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21855000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17682000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21760000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13225000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
98000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4459000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14996000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7043000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20404000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17028000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
1912000 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
1560000 usd
us-gaap Cost Of Revenue
CostOfRevenue
5754000 usd
us-gaap Cost Of Revenue
CostOfRevenue
4913000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
5544000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
4561000 usd
us-gaap Gross Profit
GrossProfit
14650000 usd
us-gaap Gross Profit
GrossProfit
12115000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3075000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2570000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9103000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6993000 usd
CY2022Q3 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
2811000 usd
CY2021Q3 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
1916000 usd
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
8358000 usd
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
4747000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3215000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1510000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8790000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4383000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
9101000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
5996000 usd
us-gaap Operating Expenses
OperatingExpenses
26251000 usd
us-gaap Operating Expenses
OperatingExpenses
16123000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3557000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1435000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11601000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4008000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000 usd
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
7000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
3000 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
320000 usd
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
5000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
632000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
6000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
781000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
781000 usd
CY2022Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-3059000 usd
CY2021Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-658000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-8535000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-3230000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3059000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-658000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8535000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3230000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25629910 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25629910 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17771134 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17771134 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4459000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1226000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
98000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20928363 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20928363 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17757363 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17757363 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3127000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
0 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
30000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3059000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
98000 usd
CY2022Q3 wdq Working Capital
WorkingCapital
10200000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
112000 usd
wdq Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
2836000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-8535000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
7241000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
178000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-658000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
6769000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9526000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
415000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3230000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
6769000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8535000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3230000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
191000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
62000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
146000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1226000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
415000 usd
wdq Increase Decrease Of Forgiveness Of Ppp Loan
IncreaseDecreaseOfForgivenessOfPPPLoan
0 usd
wdq Increase Decrease Of Forgiveness Of Ppp Loan
IncreaseDecreaseOfForgivenessOfPPPLoan
-781000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
280000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
90000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
27000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1990000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
643000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1499000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
556000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-16000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
48000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1630000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
707000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-120000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
98000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12318000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3886000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
42000 usd
wdq Origination Of Notes Receivable
OriginationOfNotesReceivable
256000 usd
wdq Origination Of Notes Receivable
OriginationOfNotesReceivable
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
143000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
429000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-399000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-471000 usd
wdq Proceeds From Reverse Recapitalization
ProceedsFromReverseRecapitalization
10185000 usd
wdq Proceeds From Reverse Recapitalization
ProceedsFromReverseRecapitalization
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
7000000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
112000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
7305000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17297000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4580000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4357000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2227000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10447000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6807000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6090000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
4496000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 usd
CY2022Q3 wdq Number Of Subsidiaries
NumberOfSubsidiaries
1 subsidiary
CY2022Q2 wdq Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.59289
CY2022Q2 wdq Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
18800000 usd
CY2022Q2 wdq Proceeds From Reverse Recapitalization Transaction Before Closing Costs
ProceedsFromReverseRecapitalizationTransactionBeforeClosingCosts
25100000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
7000000 usd
CY2022Q2 wdq Cash Acquired Through Reverse Recapitalization After Payment To Redeeming Stockholders
CashAcquiredThroughReverseRecapitalizationAfterPaymentToRedeemingStockholders
8800000 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6100000 usd
CY2022Q2 wdq Reverse Recapitalization Accrued Transaction Costs
ReverseRecapitalizationAccruedTransactionCosts
8600000 usd
CY2022Q2 wdq Reverse Recapitalization Net
ReverseRecapitalizationNet
10200000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21800000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3900000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6800000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. We base our estimates on historical experience and various other </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">assumptions that we believe to be reasonable. We believe that the assumptions and estimates associated with revenue recognition, software development costs, income taxes, and equity-based compensation have the greatest potential impact on our consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates. For further information on all of our significant accounting policies, see the Company's audited consolidated financial statements and accompanying notes included in the Company’s Registration Statement on Form S-1 filed with the SEC on July 22, 2022 and consolidated Financial Statements and Notes thereto included in Tuatara Capital Acquisition Corporation's Report on Form 10-K for the fiscal year ended December</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. Accounting estimates used in the preparation of these financial statements change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. Actual results may differ materially from these estimates.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Concentrations of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"> </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial instruments that potentially subject us to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with high credit-quality financial institutions. Such deposits may be in excess of federally insured limits. To date, we have not experienced any losses on our cash and cash equivalents. We perform periodic evaluations of the relative credit standing of the financial institutions. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We perform ongoing credit evaluations of our customers’ financial condition and require no collateral from our customers. We maintain an allowance for doubtful accounts receivable based upon the expected collectability of accounts receivable balances.</span></div>
CY2022Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5178000 usd
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
6000000 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
94000 usd
CY2022Q3 us-gaap Billed Contract Receivables
BilledContractReceivables
4463000 usd
CY2021Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
2534000 usd
CY2022Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
715000 usd
CY2021Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
806000 usd
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3340000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
451000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
295000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4727000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3045000 usd
CY2021Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
30000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
280000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
90000 usd
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
1368000 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
15000 usd
CY2022Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
968000 usd
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
828000 usd
CY2022Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
89000 usd
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
84000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2425000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
927000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
819000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
677000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
385000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
197000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
434000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
480000 usd
us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
67000 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
50000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
191000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
62000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent
250000 usd
CY2022Q2 wdq Financing Receivable Before Allowance For Credit Loss Noncurrent Interest Rate
FinancingReceivableBeforeAllowanceForCreditLossNoncurrentInterestRate
0.05
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1043000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
805000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
299000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
862000 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1000000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
176000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
55000 usd
CY2022Q3 wdq Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
2518000 usd
CY2021Q4 wdq Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
1722000 usd
CY2022Q2 wdq Reverse Recapitalization Cash Paid To Shareholders
ReverseRecapitalizationCashPaidToShareholders
191437817 usd
CY2022Q2 wdq Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
18800000 usd
CY2022Q2 wdq Proceeds From Reverse Recapitalization Transaction Before Closing Costs
ProceedsFromReverseRecapitalizationTransactionBeforeClosingCosts
25100000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
7000000 usd
CY2022Q2 wdq Cash Acquired Through Reverse Recapitalization After Payment To Redeeming Stockholders
CashAcquiredThroughReverseRecapitalizationAfterPaymentToRedeemingStockholders
8800000 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6100000 usd
CY2022Q2 wdq Cash Acquired Through Reverse Recapitalization After Payment To Redeeming Stockholders
CashAcquiredThroughReverseRecapitalizationAfterPaymentToRedeemingStockholders
8771000 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6100000 usd
CY2022Q2 wdq Proceeds From Reverse Recapitalization Operating Account
ProceedsFromReverseRecapitalizationOperatingAccount
264000 usd
CY2022Q2 wdq Proceeds From Reverse Recapitalization Transaction Before Closing Costs
ProceedsFromReverseRecapitalizationTransactionBeforeClosingCosts
25135000 usd
CY2022Q2 wdq Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
6346000 usd
CY2022Q2 wdq Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
18789000 usd
CY2022Q2 wdq Reverse Recapitalization Accrued Transaction Costs
ReverseRecapitalizationAccruedTransactionCosts
8604000 usd
CY2022Q2 wdq Reverse Recapitalization Net
ReverseRecapitalizationNet
10185000 usd
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25290270 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25290270 shares
CY2022Q2 wdq Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.59289
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
320000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
632000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
415000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
348000 usd
CY2021Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
364000 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-800000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3700000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7456000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6121000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20404000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17028000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7456000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6121000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20404000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17028000 usd
CY2022Q3 us-gaap Share Price
SharePrice
1.97
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
330000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
450000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
450000 usd
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
560000 usd
wdq Contract With Customer Liability Amounts Invoiced During The Year
ContractWithCustomerLiabilityAmountsInvoicedDuringTheYear
13627000 usd
CY2022Q1 wdq Contract With Customer Liability Amounts Invoiced During The Year
ContractWithCustomerLiabilityAmountsInvoicedDuringTheYear
13512000 usd
wdq Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
13747000 usd
CY2022Q1 wdq Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
13622000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
330000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
450000 usd
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1525175 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.05
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000 usd
CY2022Q2 wdq Share Based Compensation Arrangements By Share Based Payment Award Options Conversion Ratio
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsConversionRatio
0.5929
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3679171 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
44451 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.32
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
42629 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.11
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3592091 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.58
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3423488 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y5M19D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.55
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3300000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
13000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3423488 shares
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1300000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
169000 usd
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
192689 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
924000 usd
CY2022Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P98M
CY2022Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
202000 usd
CY2021Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
154000 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
623000 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
453000 usd
CY2022Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
805000 usd
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 wdq Preferred Stock Convertible Conversion Trigger Amount Of Initial Public Offering
PreferredStockConvertibleConversionTriggerAmountOfInitialPublicOffering
50000000 usd
CY2022Q2 wdq Preferred Stock Convertible Conversion Trigger Percent Of Total Votes
PreferredStockConvertibleConversionTriggerPercentOfTotalVotes
0.63
CY2022Q2 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
1
CY2022Q2 wdq Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.59289
CY2022Q2 wdq Sponsor Escrow Agreement Sponsor Earnout Shares
SponsorEscrowAgreementSponsorEarnoutShares
1000000 shares
CY2022Q2 wdq Sponsor Escrow Agreement Release Of Shares Stock Price Trigger
SponsorEscrowAgreementReleaseOfSharesStockPriceTrigger
12.00
CY2022Q2 wdq Sponsor Escrow Agreement Stock Price Trigger Threshold Trading Days
SponsorEscrowAgreementStockPriceTriggerThresholdTradingDays
20 day
CY2022Q2 wdq Sponsor Escrow Agreement Stock Price Trigger Threshold Trading Day Period
SponsorEscrowAgreementStockPriceTriggerThresholdTradingDayPeriod
30 day
CY2022Q2 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
350000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26211914 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26211914 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17773607 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17773607 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3059000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-658000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8535000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3230000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25629910 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25629910 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17771134 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17771134 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20928363 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20928363 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17757363 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17757363 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
160000 usd
CY2021Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
64000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
345000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
97000 usd

Files In Submission

Name View Source Status
wdq-20220930_def.xml Edgar Link unprocessable
0001801602-22-000034-index-headers.html Edgar Link pending
0001801602-22-000034-index.html Edgar Link pending
0001801602-22-000034.txt Edgar Link pending
0001801602-22-000034-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
jeff302.htm Edgar Link pending
jeff302001.jpg Edgar Link pending
jeff302002.jpg Edgar Link pending
jeff906.htm Edgar Link pending
jeff906001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
paul302.htm Edgar Link pending
paul302001.jpg Edgar Link pending
paul302002.jpg Edgar Link pending
paul906.htm Edgar Link pending
paul906001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
report.css Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
Show.js Edgar Link pending
wdq-20220930.htm Edgar Link pending
wdq-20220930.xsd Edgar Link pending
wdq-20220930_cal.xml Edgar Link unprocessable
wdq-20220930_htm.xml Edgar Link completed
wdq-20220930_pre.xml Edgar Link unprocessable
wdq-20220930_lab.xml Edgar Link unprocessable